Literature DB >> 18321501

Premature ovarian failure and dehydroepiandrosterone.

Leonidas Mamas1, Eudoxia Mamas.   

Abstract

Since the first successful birth at our center following treatment with DHEA in a patient with premature ovarian failure (POF), all subsequent patients with POF underwent the same treatment protocol. Receiving very encouraging results (FSH level was decreased in the first five patients and all achieved pregnancy), it was decided to study the action of DHEA for a reasonable length of time and in a larger number of patients to confirm the effectiveness of this particular therapeutic regime.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18321501     DOI： 10.1016/j.fertnstert.2007.11.055

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  21 in total

1.  DHEA in women with hypoandrogenism--debate remains open.

Authors:  Michał Kunicki; Krzysztof Łukaszuk; Joanna Liss
Journal:  Nat Rev Endocrinol       Date:  2015-07-14       Impact factor: 43.330

2.  The effect of 12-month dehydroepiandrosterone supplementation on the menstrual pattern, ovarian reserve markers, and safety profile in women with premature ovarian insufficiency.

Authors:  Queenie Ho Yan Wong; Tracy Wing Yee Yeung; Sofie Shuk Fei Yung; Jennifer Ka Yee Ko; Hang Wun Raymond Li; Ernest Hung Yu Ng
Journal:  J Assist Reprod Genet       Date:  2018-03-09       Impact factor: 3.412

3.  Circulating dehydroepiandrosterone sulfate levels in women who underwent bilateral salpingo-oophorectomy during the menopausal transition.

Authors:  Bill L Lasley; Sybil L Crawford; Gail A Laughlin; Nanette Santoro; Daniel S McConnell; Carolyn Crandall; Gail A Greendale; Alex J Polotsky; Marike Vuga
Journal:  Menopause       Date:  2011-05       Impact factor: 2.953

Review 4.  Adrenal androgens and the menopausal transition.

Authors:  Bill L Lasley; Sybil Crawford; Daniel S McConnell
Journal:  Obstet Gynecol Clin North Am       Date:  2011-09       Impact factor: 2.844

5.  Differential granulosa cell gene expression in young women with diminished ovarian reserve.

Authors:  Keri Greenseid; Sangita Jindal; Joshua Hurwitz; Nanette Santoro; Lubna Pal
Journal:  Reprod Sci       Date:  2011-09       Impact factor: 3.060

6.  Association of basal serum androgen levels with ovarian response and ICSI cycle outcome.

Authors:  C Abide Yayla; E Ozkaya; S Kayatas Eser; I Sanverdi; B Devranoglu; T Kutlu
Journal:  Ir J Med Sci       Date:  2017-07-25       Impact factor: 1.568

Review 7.  Dehydroepiandrosterone: A panacea for the ageing ovary?

Authors:  Nikita Naredi; K Sandeep; V D S Jamwal; N Nagraj; Seema Rai
Journal:  Med J Armed Forces India       Date:  2015-02-25

8.  Ovarian adrenal interactions during the menopausal transition.

Authors:  B L Lasley; S L Crawford; D S McConnell
Journal:  Minerva Ginecol       Date:  2013-12

9.  Is there a role for DHEA supplementation in women with diminished ovarian reserve?

Authors:  Mazen R Fouany; Fady I Sharara
Journal:  J Assist Reprod Genet       Date:  2013-06-05       Impact factor: 3.412

Review 10.  The Role of Androgen Supplementation in Women With Diminished Ovarian Reserve: Time to Randomize, Not Meta-Analyze.

Authors:  Ana Raquel Neves; Pedro Montoya-Botero; Nikolaos P Polyzos
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-17       Impact factor: 5.555
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.